Cadila Healthcare Limited

07/21/2021 | Press release | Distributed by Public on 07/21/2021 03:33

Zydus Cadila receives tentative approval from the USFDA for Ibrutinib Tablets

www.zyduscadila.com is using a security service for protection against online attacks. This process is automatic. You will be redirected once the validation is complete.

Reference ID IP Address Date and Time
620917f4067bd04eb05e9d7fb13e727e 35.183.137.234 07/21/2021 09:33 AM UTC